JP Morgan ups Hungary’s Richter target price

Portfolio
JP Morgan has raised its target price for Hungarian pharmaceutical blue chip Richter to HUF 8,200, 18.8% higher than the share's Friday closing price.
JPMorgan

The recommendation for the share was raised to ‘Overweight’ from ‘Neutral’.

According to the Reuters database, Richter has 6 ‘Buy’ and 2 ‘Hold’ recommendations, with no analyst recommending selling the stock. The average analyst target price is HUF 7,368, 6.7% above the Friday closing price.

Richter shares rose 2.7% on Friday and have gained 7.6% this year.

RICHTER

Cover photo: Daniel Fung/SOPA Images/LightRocket via Getty Images

 

More in Business

February 27, 2026 10:22

Freight traffic begins on the Budapest–Belgrade railway line

Testing the tracks

elektromos autó töltés töltőpont plug
February 18, 2026 13:35

Sad truth about plug-in hybrids revealed: shocking figures uncovered in a study

There are significant differences between everyday use and factory values

gazdag vagyon arany kincs láda érem-arany-befektetés-befektető-érme-gazdagság-kincs-megtakarítás-pénz-tőke-vagyon
February 16, 2026 11:42

Erste, Shell respond to Hungarian PM's acerbic remarks

Campaign speech raises brows

LATEST NEWS
Charting is displayed using TradingView's technology, a platform, where you can build advanced charts, spot upcoming trends in the stock screener, and find inspiration in multiple trading ideas

Detailed search